- Home
- STRO vs REAL Comparison
STRO vs REAL Comparison
Compare STRO & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- REAL
- Stock Information
- Founded
- STRO 2003
- REAL 2011
- Country
- STRO United States
- REAL United States
- Employees
- STRO N/A
- REAL N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- REAL Other Specialty Stores
- Sector
- STRO Health Care
- REAL Consumer Discretionary
- Exchange
- STRO Nasdaq
- REAL Nasdaq
- Market Cap
- STRO 172.8M
- REAL 1.2B
- IPO Year
- STRO 2018
- REAL 2019
- Fundamental
- Price
- STRO $1.96
- REAL $9.58
- Analyst Decision
- STRO Strong Buy
- REAL Buy
- Analyst Count
- STRO 7
- REAL 6
- Target Price
- STRO $12.14
- REAL $7.04
- AVG Volume (30 Days)
- STRO 1.4M
- REAL 4.2M
- Earning Date
- STRO 11-13-2024
- REAL 02-27-2025
- Dividend Yield
- STRO N/A
- REAL N/A
- EPS Growth
- STRO N/A
- REAL N/A
- EPS
- STRO N/A
- REAL N/A
- Revenue
- STRO $160,955,000.00
- REAL $579,862,000.00
- Revenue This Year
- STRO N/A
- REAL $11.26
- Revenue Next Year
- STRO N/A
- REAL $8.81
- P/E Ratio
- STRO N/A
- REAL N/A
- Revenue Growth
- STRO 230.90
- REAL 2.52
- 52 Week Low
- STRO $1.70
- REAL $1.52
- 52 Week High
- STRO $6.13
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- STRO 37.11
- REAL 74.41
- Support Level
- STRO $1.80
- REAL $9.00
- Resistance Level
- STRO $2.01
- REAL $11.38
- Average True Range (ATR)
- STRO 0.16
- REAL 0.78
- MACD
- STRO 0.03
- REAL 0.05
- Stochastic Oscillator
- STRO 37.18
- REAL 80.54
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.